ReviewDer Nervenarzt2026
[Artificial intelligence in the early detection of psychotic disorders: opportunities and limitations of clinical implementation].
Review in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of psychotic disorders is complicated by nonspecific symptoms, heterogeneous trajectories and the limited ability of established clinical instruments to generate accurate individual-level predictions. Data-driven artificial intelligence can integrate complex clinical and biological data and achieves moderate to good predictive performance, which often declines on external validation. Despite substantial methodological advances, a marked translational gap between model development and clinical application persists, mainly due to limited generalizability as well as practical, ethical and regulatory requirements. Artificial intelligence can complement clinical expertise and facilitate access to appropriate psychiatric care provided that it is implemented transparently and close to real-world care, subject to health economic evaluation and developed with the active involvement of experts by experience.
Indexed as
Identifiers
42918865What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.